Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

74.4K
Overview
74.4K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

41
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
41
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

58
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversity and inclusion at scientific conferences.

Sexual health·2026
Same author

Implantation mycoses: A nationwide survey on diagnostic and treatment modalities in Nepal.

PLoS neglected tropical diseases·2026
Same author

Establishing a Consumer Panel to Inform Health Technology Assessment Processes and Policy: impact and insights from Singapore's experience.

International journal of technology assessment in health care·2026
Same author

Health-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L.

Orphanet journal of rare diseases·2026
Same author

The Lancet Commission on Skin Health: aligning with WHO priorities.

Lancet (London, England)·2026
Same author

P15 Scabies in pediatric population in Nepal: a study from tertiary-care referral children's hospital.

The British journal of dermatology·2025

Related Experiment Video

Updated: Jul 21, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

Genodermatoses Picture: Difficulties Faced And Way Forward in Nepal.

Niraj Parajuli1, Rabindra Baskota2, Ritu Jain3

  • 1Department of Dermatology and Venereology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.

Journal of Nepal Health Research Council
|July 25, 2023
PubMed
Summary

Genodermatoses, rare genetic skin disorders, lack defined prevalence in Nepal due to diagnostic challenges. Establishing specialized centers and reporting systems is crucial for patient well-being and addressing lifelong disability.

More Related Videos

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

10.0K
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 21, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

10.0K
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

1.7K

Area of Science:

  • Dermatology
  • Genetics
  • Public Health

Background:

  • Genodermatoses are rare genetic disorders with skin manifestations.
  • Their prevalence is often unknown due to rarity and diagnostic complexities.
  • Affected individuals face lifelong disability and social stigma.

Purpose of the Study:

  • To highlight the need for specialized diagnostic centers for genodermatoses in Nepal.
  • To advocate for improved reporting systems for rare diseases.
  • To align rare disease management with sustainable development goals.

Main Methods:

  • Literature review on genodermatoses prevalence and diagnosis.
  • Analysis of current healthcare infrastructure in Nepal for rare diseases.
  • Policy recommendations for government and healthcare providers.

Main Results:

  • Significant gaps exist in the diagnosis and reporting of genodermatoses in Nepal.
  • Lack of specialized centers hinders accurate diagnosis and management.
  • Patient support groups can play a role in reducing stigma.

Conclusions:

  • Specialized centers and a robust reporting system are essential for genodermatoses in Nepal.
  • Government prioritization and patient engagement are key to improving outcomes.
  • Addressing rare diseases aligns with global health and well-being initiatives.